RO
Robert Orlowski
Hematology & Oncology
Credentials: ·
History
- 2011–2014
Internal Medicine
- 2007–2011
Medical School
Research
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Nature · 2017 · 1,395 citations
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
New England Journal of Medicine · 2022 · 797 citations
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
Nature Medicine · 2019 · 588 citations
- VM
11 papers
4 papers
4 papers
4 papers
3 papers
3 papers · 3 as a fellow
- AC
3 papers
- CA
3 papers
